# Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers

> **NCT00617292** · — · UNKNOWN · sponsor: **Office of Rare Diseases (ORD)** · enrollment: 233 (estimated)

## Conditions studied

- Adrenal Hyperplasia, Congenital

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00617292
- **Lead sponsor:** Office of Rare Diseases (ORD)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 233 (ESTIMATED)
- **Last updated:** 2008-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617292, "Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00617292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*